Inherited isolated arrhythmogenic cardiomyopathy

Palpitations manifest as an awareness of the heart beating irregularly or forcefully. This symptom is caused by the disruption of normal electrical conduction in the heart due to structural changes in cardiac tissue. Over time, palpitations may become more frequent and severe as the disease progresses. They can significantly affect daily life by causing anxiety and discomfort, and management often includes medications like beta-blockers to stabilize heart rhythm.

Fatigue presents as a persistent feeling of tiredness and lack of energy. It results from the heart's reduced ability to pump blood efficiently, leading to decreased oxygen delivery to tissues. As the condition progresses, fatigue can worsen, making it difficult for patients to engage in physical activities. Lifestyle modifications and cardiac rehabilitation can help manage this symptom and improve quality of life.

Shortness of breath, or dyspnea, occurs when the heart cannot pump effectively, leading to fluid buildup in the lungs. This symptom is due to increased pressure in the pulmonary circulation as a result of heart failure. It tends to worsen with exertion and as the disease advances. Patients may need to limit physical activity and use medications like diuretics to alleviate symptoms.

Dizziness is characterized by a sensation of lightheadedness or feeling faint. It occurs due to inadequate blood flow to the brain, often resulting from arrhythmias or heart failure. This symptom can become more pronounced with disease progression, potentially leading to fainting episodes. Patients are advised to avoid sudden changes in posture and may require medication adjustments to manage this symptom.

Chest pain can manifest as a sharp, stabbing, or pressure-like sensation in the chest. It is often caused by ischemia due to compromised blood flow or stress on the heart muscle. Over time, chest pain may become more frequent, especially during physical exertion or stress. Management includes lifestyle changes, medications, and in some cases, surgical interventions to improve blood flow.

Swelling, or edema, in the legs and ankles is due to fluid retention as the heart's pumping efficiency declines. This symptom is caused by increased venous pressure and fluid leakage into surrounding tissues. As the condition progresses, swelling can become more pronounced and persistent. Elevating the legs and using compression stockings can help manage this symptom, along with diuretics to reduce fluid buildup.

Syncope is a temporary loss of consciousness, often described as fainting. It occurs when the brain receives insufficient blood flow, frequently due to arrhythmias. This symptom may become more frequent with disease progression, posing a risk for injury. Patients are advised to avoid triggers and may require pacemaker implantation to prevent episodes.

Heart failure manifests as the heart's inability to pump blood effectively, leading to symptoms like fatigue, shortness of breath, and fluid retention. It results from progressive damage to cardiac tissue and impaired contractility. Over time, heart failure can significantly impact daily activities and quality of life. Management includes medications, lifestyle changes, and potentially advanced therapies like cardiac resynchronization therapy.

Clinicians look for symptoms such as palpitations, syncope, or sudden cardiac arrest, which may suggest arrhythmogenic cardiomyopathy. A detailed family history is crucial, as a positive family history of similar symptoms or sudden cardiac death can indicate a hereditary pattern. Physical examination may reveal signs of heart failure or arrhythmias, guiding further diagnostic testing. This step helps to identify patients who require more detailed cardiac evaluation and genetic testing.

Cardiac MRI is the imaging modality of choice, revealing structural abnormalities such as ventricular dilation or fibrofatty infiltration. These findings help confirm the diagnosis by showing characteristic changes in the heart muscle associated with arrhythmogenic cardiomyopathy. Imaging can exclude other conditions like dilated cardiomyopathy or myocarditis, which may present similarly. The results of imaging studies are critical in confirming the diagnosis and assessing the extent of cardiac involvement.

Blood tests may include cardiac biomarkers like troponins and BNP, which can indicate myocardial stress or damage. Elevated levels of these biomarkers suggest cardiac involvement and may correlate with disease severity. Abnormal results prompt further investigation and monitoring, helping to assess the risk of arrhythmias or heart failure. Laboratory tests guide the clinical management and monitoring of disease progression.

Genetic testing focuses on sequencing genes such as JUP, DSP, and DSG2, which are commonly associated with arrhythmogenic cardiomyopathy. Mutations in these genes, particularly nonsense or missense mutations, confirm the diagnosis and indicate a hereditary pattern. Positive genetic results provide definitive evidence of the condition and are essential for family counseling and risk assessment. Genetic testing informs family members about their potential risk and guides decisions regarding surveillance and preventive measures.